• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Enforcement Report - Week of July 10, 2024

    FDA

    Hetero`s Generic Eszopiclone Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of July 13, 2022

    FDA

    Taiwan bans four types of sleeping pills for certain patients

    TAIWANNEWS

    Sleeping Pills Get Black Box Warning Following Accidental Deaths

    ORGANICCONSUMER

    Breckenridge Pharm`s Generic Eszopiclone Receives Approval in US

    FDA

    FDA requires stronger warnings about rare serious incidents insomnia medicines

    PR NEWSWIRE

    FDA Adds Boxed Warnings to Insomnia Medicines Following Injuries, Deaths

    RAPS

    Aurobindo Pharma`s Generic Eszopiclone Approved In US

    FDA

    Real-life insomnia stories at core of new Merck-backed awareness campaign

    FIERCE PHARMA MARKETING

    Sunovion prepares for FDA decision on Aptiom

    MMM

    Merck`s Quest To Revive The Market For Insomnia Drugs

    FORBES

    8 Invented Diseases Big Pharma Is Banking On

    ALTERNET

    FDA Releases New Recommendations to Ensure Drugs Don`t Cause Car Accidents

    RAPS

    Sunovion Pharmaceuticals Inc Files Patent Infringement Lawsuits Regarding Latuda

    SUNOVION

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.